1. Home
  2. Research & Funding
  3. Current Funding Opportunities
  4. Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)

Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)

The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available a www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.

Funding Opportunity Details

PAR-22-111
NOT-OD-22-190

Yan Li, Ph.D.; Bonnie Burgess-Beusse, Ph.D.; Anna Sadusky, Ph.D.

Key Dates

6/14/2022

June 14, 2022, October 14, 2022, June 14, 2023, October 13, 2023, June 12, 2024, and October 12, 2024